Correction: Effect of low vs. high Vancomycin trough level on the clinical outcomes of adult patients with sepsis or gram-positive bacterial infections: a systematic review and meta-analysis.
作者信息
Chander Subhash, Kumari Roopa, Yu Wang Hong, Nadeem Mohammed Yaqub, Parkash Om, Lohana Sindhu, Sorath Fnu, Chand Lohana Abhi, Sadarat Fnu, Shiwlani Sheena
机构信息
Department of Medicine, Icahn School of Medicine, Mount Sinai, New York, NY, USA.
Mount Sinai Beth Israel Hospital, 281 1st Ave, New York, NY, 10003, USA.
出版信息
BMC Infect Dis. 2025 Mar 17;25(1):371. doi: 10.1186/s12879-025-10745-5.
Abstract
摘要
相似文献
1
Correction: Effect of low vs. high Vancomycin trough level on the clinical outcomes of adult patients with sepsis or gram-positive bacterial infections: a systematic review and meta-analysis.更正：低与高万古霉素谷浓度对成年脓毒症或革兰氏阳性菌感染患者临床结局的影响：一项系统评价和荟萃分析。
BMC Infect Dis. 2025 Mar 17;25(1):371. doi: 10.1186/s12879-025-10745-5.
2
Effect of low vs. high vancomycin trough level on the clinical outcomes of adult patients with sepsis or gram-positive bacterial infections: a systematic review and meta-analysis.低与高万古霉素谷浓度对脓毒症或革兰阳性菌感染成年患者临床结局的影响：系统评价和荟萃分析。
BMC Infect Dis. 2024 Oct 7;24(1):1114. doi: 10.1186/s12879-024-09927-4.
3
Vancomycin efficiency and safety of a dosage of 40-60 mg/kg/d and corresponding trough concentrations in children with Gram-positive bacterial sepsis.万古霉素 40-60mg/kg/d 剂量及其谷浓度在儿童革兰阳性菌败血症中的疗效和安全性。
Front Cell Infect Microbiol. 2023 Apr 3;13:1117717. doi: 10.3389/fcimb.2023.1117717. eCollection 2023.
4
[Clinical efficacy and safety of vancomycin compared with linezolid for the treatment of neonatal gram-positive bacterial sepsis].万古霉素与利奈唑胺治疗新生儿革兰氏阳性菌败血症的临床疗效及安全性比较
Zhonghua Er Ke Za Zhi. 2016 Sep;54(9):686-91. doi: 10.3760/cma.j.issn.0578-1310.2016.09.011.
5
Systematic review and meta-analysis to explore optimal therapeutic range of vancomycin trough level for infected paediatric patients with Gram-positive pathogens to reduce mortality and nephrotoxicity risk.系统评价和荟萃分析，以探索万古霉素谷浓度在感染革兰氏阳性病原体的儿科患者中的最佳治疗范围，以降低死亡率和肾毒性风险。
Int J Antimicrob Agents. 2021 Aug;58(2):106393. doi: 10.1016/j.ijantimicag.2021.106393. Epub 2021 Jun 24.
6
Vancomycin serum trough concentration vs. clinical outcome in patients with gram-positive infection: a retrospective analysis.革兰氏阳性感染患者万古霉素血清谷浓度与临床结局的回顾性分析
J Clin Pharm Ther. 2015 Dec;40(6):640-4. doi: 10.1111/jcpt.12323. Epub 2015 Sep 18.
7
High versus low vancomycin serum trough regimen for Gram-positive infections: a meta-analysis.
J Chemother. 2015 Aug;27(4):213-20. doi: 10.1179/1973947814Y.0000000182. Epub 2014 Mar 18.
8
Systematic review and meta-analysis of vancomycin therapeutic level for treatment of vancomycin-sensitive enterococcal infections.万古霉素治疗敏感肠球菌感染的治疗水平的系统评价和荟萃分析。
Br J Clin Pharmacol. 2025 Apr;91(4):1250-1262. doi: 10.1111/bcp.16362. Epub 2024 Dec 8.
9
Association of Initial Trough Concentrations of Vancomycin with Outcomes in Pediatric Patients with Gram-Positive Bacterial Infection.万古霉素初始谷浓度与儿童革兰阳性菌感染患者结局的相关性。
Biol Pharm Bull. 2020;43(10):1463-1468. doi: 10.1248/bpb.b19-01003.
10
Vancomycin Dosage and Its Association with Clinical Outcomes in Pediatric Patients with Gram-Positive Bacterial Infections.万古霉素剂量及其与革兰氏阳性菌感染儿科患者临床结局的关联。
Risk Manag Healthc Policy. 2020 Jun 29;13:685-695. doi: 10.2147/RMHP.S244836. eCollection 2020.
本文引用的文献
1
Effect of low vs. high vancomycin trough level on the clinical outcomes of adult patients with sepsis or gram-positive bacterial infections: a systematic review and meta-analysis.低与高万古霉素谷浓度对脓毒症或革兰阳性菌感染成年患者临床结局的影响：系统评价和荟萃分析。
BMC Infect Dis. 2024 Oct 7;24(1):1114. doi: 10.1186/s12879-024-09927-4.
Zotero 插件